Pro Medicus (OTCMKTS:PMCUF) Stock Price Down 1.6% – Here’s Why

Pro Medicus Limited (OTCMKTS:PMCUF)’s stock price fell 1.6% during trading on Thursday . The stock traded as low as $96.47 and last traded at $96.47. 50 shares changed hands during mid-day trading, a decline of 92% from the average session volume of 624 shares. The stock had previously closed at $98.00.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group set a $155.00 price objective on shares of Pro Medicus and gave the stock a “buy” rating in a research report on Thursday, February 12th. One analyst has rated the stock with a Buy rating, According to MarketBeat.com, Pro Medicus currently has a consensus rating of “Buy” and an average price target of $155.00.

Pro Medicus Price Performance

The business’s 50-day simple moving average is $90.38 and its 200-day simple moving average is $127.73.

Pro Medicus Company Profile

Pro Medicus Limited is an Australia?based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.

The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.